Form 4: Encompass Health Director Kevin J. O'Connor Reports Acquisition of Additional Restricted Stock Units Due to Dividend Payment

Kevin J. O'Connor, a director of Encompass Health Corp, reported the acquisition of 11 restricted stock units (RSUs) due to a dividend payment on April 15, 2024.

Summary

• On April 16, 2024, Kevin J. O'Connor, a director of Encompass Health Corp, filed a Form 4 with the SEC.
• The report details the acquisition of 11 restricted stock units (RSUs) on April 15, 2024, resulting from a dividend payment.
• These RSUs were credited to O'Connor's account as a non-employee director in connection with common stock dividend payments.
• The dividend paid was $0.15 per share, and the closing price of Encompass Health's common stock on the dividend payment date was $80.73.
• Following the transaction, O'Connor beneficially owns 6,410 shares of Encompass Health common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects standard compensation practices and dividend payments, indicating a stable financial position.

Positives

• The acquisition of RSUs indicates continued alignment of the director's interests with those of the shareholders.
• The dividend payment reflects Encompass Health's commitment to returning value to its shareholders.

Industry Context

This filing is a routine disclosure related to director compensation and dividend payments, common in publicly traded companies. It reflects standard corporate governance practices.

Stakeholder Impact

• Shareholders may view the dividend payment and director's RSU acquisition positively, as it reflects a commitment to returning value and aligning interests.

Key Dates